World Health Organisation (1981) The collection, fractionation, quality control, and uses of blood and blood products.WHO, Geneva, Switzerland.
2.
Lunsgaard-HansenP.: Volume limitations of plasmapheresis.Vox Sang.,32, 20–25, 1977.
3.
CookI.A., RossD.W., and GordonI..: Recruitment and plasmapheresis of donors to provide human antitetanus immunoglobulin.J. Clin. Path.29, 211–214, 1976.
4.
GunsonH.H., StrattonF., and PhillipsP.K..: The anti-Rh (D) responses of immunised volunteers following repeated antigenic stimuli.Brit. J. Haematol.32, 331–340, 1976.
5.
HogmanC.F., AndreenR., RosenI., AkerblomO., and HellsingK..: Haemotherapy with red-cell concentrates and a new red-cells storage medium.Lancet,1, 269–271, 1983.
6.
VermylenC.: Self-sufficiency for plasma in Belgium.Haemostasis.10(Suppl. 1.), 57, 1981.
7.
BayerW.L.: Coagulation studies in a broadly based volunteer plasma procurement program using the haemonetics 50.Proceedings of the H.R.I. Advanced Component Seminar1979.
8.
RobinsonE.A., PennyA.F., SmithJ., and ToveyD.L..: Pilot study for large-scale plasma procurement using automated plasmapheresis.Vox. Sang.44, 143–150, 1983.
9.
SalvaggioJ., ArquembourgP., BickersJ., and BiceD..: The effect of prolonged plasmapheresis on immunoglobulins, other serum proteins, delayed hypersensitivity and phytohaemagglutinin-induced lymphocyte transformation.Int. Arch. Allergy,41, 883–894, 1971.